000566 海南海藥
按盤價 
6.770 +0.620 (+10.081%)
6.770 +0.620 (+10.081%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 639,684 | -20.51% | 990,701 | 1,478,581 | 1,779,052 | 2,059,063 | |
| 減：營業總成本 | 926,346 | -11.99% | 1,398,077 | 1,676,028 | 1,969,736 | 2,529,698 | |
| 其中:營業成本 | 475,306 | -9.46% | 641,692 | 908,457 | 1,010,824 | 1,228,044 | |
| 財務費用 | 125,086 | 2.62% | 175,729 | 155,592 | 167,253 | 198,009 | |
| 資產減值損失 | (206) | -96.23% | (361,749) | (1,087) | (1,811) | (374,360) | |
| 公允價值變動收益 | 168 | -156.44% | (357,385) | 30,384 | (57,761) | (190,938) | |
| 投資收益 | 6,039 | -112.07% | (68,357) | (12,629) | 254,987 | 28,807 | |
| 其中：對聯營企業和合營企業的投資收益 | (6,720) | -38.92% | (40,352) | (48,884) | -- | (32,050) | |
| 營業利潤 | (258,157) | -15.37% | (1,549,949) | (120,651) | (61,485) | (1,551,211) | |
| 利潤總額 | (258,989) | -16.09% | (1,561,164) | (118,574) | (58,896) | (1,555,973) | |
| 減：所得稅費用 | 3,657 | -27.11% | 34,037 | 16,780 | (61,264) | 41,652 | |
| 淨利潤 | (262,646) | -16.27% | (1,595,201) | (135,354) | 2,368 | (1,597,626) | |
| 減：非控股權益 | (20,338) | 10.00% | (70,000) | (28,866) | (8,139) | (42,210) | |
| 股東淨利潤 | (242,307) | -17.91% | (1,525,201) | (106,489) | 10,507 | (1,555,415) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.187 | -17.89% | -1.176 | -0.082 | 0.008 | -1.199 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 0.215 | -84.25% | 0.405 | 1.590 | 1.669 | 1.657 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 14/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
